Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Breast cancer: An insight into its inflammatory, molecular, pathological and targeted facets with update on investigational drugs
Ranjit K. Harwansh, Rohitas Deshmukh
Critical Reviews in Oncology/Hematology (2020) Vol. 154, pp. 103070-103070
Closed Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Targeted delivery of albumin nanoparticles for breast cancer: A review
Shalvi Sinai Kunde, Sarika Wairkar
Colloids and Surfaces B Biointerfaces (2022) Vol. 213, pp. 112422-112422
Closed Access | Times Cited: 51
New insights into therapeutic applications and nanoformulation approaches of hesperidin: An updated review
Keshav Bansal, Hemant Bhati, Vanshita Singh, et al.
Pharmacological Research - Modern Chinese Medicine (2024) Vol. 10, pp. 100363-100363
Open Access | Times Cited: 10
A glance on gold nanoparticle: An emerging theranostic tool for oncology
Rajesh Singh, Ashwini Kumar Mishra, Bharat Bhushan, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 97, pp. 105766-105766
Closed Access | Times Cited: 8
Development and optimization of nanoemulsion containing exemestane using box-behnken design
Shashank Chaturvedi, Anuj Garg
Journal of Drug Delivery Science and Technology (2023) Vol. 80, pp. 104151-104151
Closed Access | Times Cited: 20
Causes and Risk Factors of Breast Cancer, What Do We Know for Sure? An Evidence Synthesis of Systematic Reviews and Meta-Analyses
Borghild Løyland, Ida Hellum Sandbekken, Ellen Karine Grov, et al.
Cancers (2024) Vol. 16, Iss. 8, pp. 1583-1583
Open Access | Times Cited: 6
Andrographis paniculata and Andrographolide - A Snapshot on Recent Advances in Nano Drug Delivery Systems against Cancer
Rohitas Deshmukh, Aman Jain, Rajesh Singh, et al.
Current Drug Delivery (2023) Vol. 21, Iss. 5, pp. 631-644
Closed Access | Times Cited: 13
Dual‐Gating Strategy: Ultrasound Activation of TRPV2 Channels and Borate‐Glass‐Induced Calcium Overload for Tumor Suppression
Hai-Hong Zhu, Liping Ouyang, Yijie Huang, et al.
Advanced Science (2025)
Open Access
Harnessing Lipid Polymer Hybrid Nanoparticles for Enhanced Oral Bioavailability of Thymoquinone: In Vitro and In Vivo Assessments
Syed Sarim Imam, Sadaf Jamal Gilani, May Bin‐Jumah, et al.
Polymers (2022) Vol. 14, Iss. 18, pp. 3705-3705
Open Access | Times Cited: 19
An insight on nanofibers assisted localized delivery of anti-cancer drugs to breast for an effective breast cancer treatment
Shashank Chaturvedi, Vaibhav Rastogi, M. Aravind Kumar
Journal of Drug Delivery Science and Technology (2024) Vol. 93, pp. 105447-105447
Closed Access | Times Cited: 4
Evaluation of the Interaction between Carvacrol and Thymol, Major Compounds of Ptychotis verticillata Essential Oil: Antioxidant, Anti-Inflammatory and Anticancer Activities against Breast Cancer Lines
Mohamed Taibi, Amine Elbouzidi, Mounir Haddou, et al.
Life (2024) Vol. 14, Iss. 8, pp. 1037-1037
Open Access | Times Cited: 4
Electrochemical Immunosensor based on NiO for CA 15-3 detection and Agent-Based Modelling for Treatment Optimization
Kashima Arora, Vishal Gupta, Akshta Rajan, et al.
Electrochimica Acta (2025), pp. 145708-145708
Closed Access
Carbon nanotube as an emerging theranostic tool for oncology
Rajesh Singh, Rohitas Deshmukh
Journal of Drug Delivery Science and Technology (2022) Vol. 74, pp. 103586-103586
Closed Access | Times Cited: 17
DNA Nanobots – Emerging Customized Nanomedicine in Oncology
Rohitas Deshmukh, Rajesh Singh
Current Drug Delivery (2022) Vol. 20, Iss. 2, pp. 111-126
Closed Access | Times Cited: 16
Polymeric nanomaterials-based theranostic platforms for triple-negative breast cancer (TNBC) treatment
Sudhakar Reddy Baddam, Srinivas Ganta, Seshadri Nalla, et al.
International Journal of Pharmaceutics (2024) Vol. 660, pp. 124346-124346
Closed Access | Times Cited: 2
Hyaluronic Acid-Modified Nanoparticles Self-Assembled from Linoleic Acid-Conjugated Chitosan for the Codelivery of miR34a and Doxorubicin in Resistant Breast Cancer
Xiaoxia Yang, Pengfei Shang, Jianbo Ji, et al.
Molecular Pharmaceutics (2021) Vol. 19, Iss. 1, pp. 2-17
Closed Access | Times Cited: 17
Role of adipose tissue-derived cytokines in the progression of inflammatory breast cancer in patients with obesity
Aya Saber Ibrahim, Mohamed El‐Shinawi, Salwa Sabet, et al.
Lipids in Health and Disease (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 12
Simultaneous Determination of Polyamines and Steroids in Human Serum from Breast Cancer Patients Using Liquid Chromatography–Tandem Mass Spectrometry
Yu Ra Lee, Ji‐Won Lee, Jongki Hong, et al.
Molecules (2021) Vol. 26, Iss. 4, pp. 1153-1153
Open Access | Times Cited: 13
Folic acid anchored urchin-like raloxifene nanoparticles for receptor targeting in breast cancer: Synthesis, optimisation and in vitro biological evaluation
Shalvi Sinai Kunde, Sarika Wairkar
International Journal of Pharmaceutics (2022) Vol. 623, pp. 121926-121926
Closed Access | Times Cited: 9
Bioactive Exploration in Functional Foods: Unlocking Nature's Treasures
Ravi Kumar Mittal, Raghav Mishra, Vikram Sharma, et al.
Current Pharmaceutical Biotechnology (2023) Vol. 25, Iss. 11, pp. 1419-1435
Closed Access | Times Cited: 5
Management of Colorectal Cancer Using Nanocarriers-based Drug Delivery for Herbal Bioactives: Current and Emerging Approaches
Rohitas Deshmukh, Mahendra Kumar Prajapati, Ranjit K. Harwansh
Current Pharmaceutical Biotechnology (2023) Vol. 25, Iss. 5, pp. 599-622
Closed Access | Times Cited: 4
pDNA-tachyplesin treatment stimulates the immune system and increases the probability of apoptosis in MC4-L2 tumor cells
Fatemeh Mahmoudi-Filabadi, Abbas Doosti
Amino Acids (2024) Vol. 56, Iss. 1
Open Access | Times Cited: 1
In vitro evaluation of dioscin and protodioscin against ER-positive and triple-negative breast cancer
Najat Bouchmaa, Reda Ben Mrid, Youssef Bouargalne, et al.
PLoS ONE (2023) Vol. 18, Iss. 2, pp. e0272781-e0272781
Open Access | Times Cited: 3
Thymoquinone: A novel treatment option for triple negative breast cancer
Vani Mamillapalli, Vinuthna Rallapalli, Z M A Mohammed, et al.
Biomedicine (2024) Vol. 44, Iss. 1, pp. 13-20
Open Access
Electroceuticals: Unlocking the promise of therapies
Isha Mishra, Kajal Chaudhary, Vikram Sharma, et al.
DARU Journal of Pharmaceutical Sciences (2024) Vol. 33, Iss. 1
Closed Access
An Insight on Skin Cancer About Different Targets With Update on Clinical Trials and Investigational Drugs
Suraj Vishwas, Swarnali Das Paul, Deepika Singh
Current Drug Delivery (2023) Vol. 21, Iss. 6, pp. 852-869
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top